adenosine A3 receptor agonists

Preferred Label : adenosine A3 receptor agonists;

MeSH definition : Drugs that selectively bind to and activate ADENOSINE A3 RECEPTORS.;

Is substance : O;

Détails

Origin ID

D058909;

UMLS CUI

C2936553;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
MeSH Descriptor(s) used for indexing
- receptor, adenosine a3 [MeSH Descriptor]
Record concept(s)
- adenosine A3 receptor agonists [MeSH concept]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- 2-chloro-N(6)-(3-iodobenzyl)-5'-N-methylcarbamoyl-4'-thioadenosine [MeSH Supplementary Concept]
- 2-chloro-N(6)-methyladenosine-5'-methyluronamide [MeSH Supplementary Concept]
- 4'-(2-chloro-6-(3-iodobenzylamino)purine)-2',3'-O-dihydroxy-bicyclo(3.1.0)hexane [MeSH Supplementary Concept]
- ABEA-X-BY630 [MeSH Supplementary Concept]
- CF 502 [MeSH Supplementary Concept]
- N6-methoxy-2-(4-acetylphenyl)ethynyl-5'-N-methylcarboxamidoadenosine [MeSH Supplementary Concept]

Position du mot-clé dans l'(les) arborescence(s) :

Vous pouvez consulter :

recommendations
documents concerning education
documents for patients